Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

MutT homolog 1 counteracts the effect of anti-neoplastic treatments in adult and pediatric glioblastoma cells.

Versano Z, Shany E, Freedman S, Tuval-Kochen L, Leitner M, Paglin S, Toren A, Yalon M.

Oncotarget. 2018 Jun 8;9(44):27547-27563. doi: 10.18632/oncotarget.25547. eCollection 2018 Jun 8.

2.

Correction: Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations.

Yalon M, Tuval-Kochen L, Castel D, Moshe I, Mazal I, Cohen O, Avivi C, Rosenblatt K, Aviel-Ronen S, Schiby G, Yahalom J, Amariglio N, Pfeffer R, Lawrence YR, Toren A, Rechavi G, Paglin S.

PLoS One. 2016 Aug 22;11(8):e0161799. doi: 10.1371/journal.pone.0161799. eCollection 2016.

3.

Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations.

Yalon M, Tuval-Kochen L, Castel D, Moshe I, Mazal I, Cohen O, Avivi C, Rosenblatt K, Aviel-Ronen S, Schiby G, Yahalom J, Amariglio N, Pfeffer R, Lawrence Y, Toren A, Rechavi G, Paglin S.

PLoS One. 2016 May 19;11(5):e0155711. doi: 10.1371/journal.pone.0155711. eCollection 2016. Erratum in: PLoS One. 2016;11(8):e0161799.

4.

Eukaryotic initiation factor 2α--a downstream effector of mammalian target of rapamycin--modulates DNA repair and cancer response to treatment.

Tuval-Kochen L, Paglin S, Keshet G, Lerenthal Y, Nakar C, Golani T, Toren A, Yahalom J, Pfeffer R, Lawrence Y.

PLoS One. 2013 Oct 25;8(10):e77260. doi: 10.1371/journal.pone.0077260. eCollection 2013.

5.

Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility.

Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, Wolf I, Kanety H, Sredni B, Meirow D.

Sci Transl Med. 2013 May 15;5(185):185ra62. doi: 10.1126/scitranslmed.3005402.

6.

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes.

Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A, Bamber BA, Bassham DC, Bergamini E, Bi X, Biard-Piechaczyk M, Blum JS, Bredesen DE, Brodsky JL, Brumell JH, Brunk UT, Bursch W, Camougrand N, Cebollero E, Cecconi F, Chen Y, Chin LS, Choi A, Chu CT, Chung J, Clarke PG, Clark RS, Clarke SG, Clavé C, Cleveland JL, Codogno P, Colombo MI, Coto-Montes A, Cregg JM, Cuervo AM, Debnath J, Demarchi F, Dennis PB, Dennis PA, Deretic V, Devenish RJ, Di Sano F, Dice JF, Difiglia M, Dinesh-Kumar S, Distelhorst CW, Djavaheri-Mergny M, Dorsey FC, Dröge W, Dron M, Dunn WA Jr, Duszenko M, Eissa NT, Elazar Z, Esclatine A, Eskelinen EL, Fésüs L, Finley KD, Fuentes JM, Fueyo J, Fujisaki K, Galliot B, Gao FB, Gewirtz DA, Gibson SB, Gohla A, Goldberg AL, Gonzalez R, González-Estévez C, Gorski S, Gottlieb RA, Häussinger D, He YW, Heidenreich K, Hill JA, Høyer-Hansen M, Hu X, Huang WP, Iwasaki A, Jäättelä M, Jackson WT, Jiang X, Jin S, Johansen T, Jung JU, Kadowaki M, Kang C, Kelekar A, Kessel DH, Kiel JA, Kim HP, Kimchi A, Kinsella TJ, Kiselyov K, Kitamoto K, Knecht E, Komatsu M, Kominami E, Kondo S, Kovács AL, Kroemer G, Kuan CY, Kumar R, Kundu M, Landry J, Laporte M, Le W, Lei HY, Lenardo MJ, Levine B, Lieberman A, Lim KL, Lin FC, Liou W, Liu LF, Lopez-Berestein G, López-Otín C, Lu B, Macleod KF, Malorni W, Martinet W, Matsuoka K, Mautner J, Meijer AJ, Meléndez A, Michels P, Miotto G, Mistiaen WP, Mizushima N, Mograbi B, Monastyrska I, Moore MN, Moreira PI, Moriyasu Y, Motyl T, Münz C, Murphy LO, Naqvi NI, Neufeld TP, Nishino I, Nixon RA, Noda T, Nürnberg B, Ogawa M, Oleinick NL, Olsen LJ, Ozpolat B, Paglin S, Palmer GE, Papassideri I, Parkes M, Perlmutter DH, Perry G, Piacentini M, Pinkas-Kramarski R, Prescott M, Proikas-Cezanne T, Raben N, Rami A, Reggiori F, Rohrer B, Rubinsztein DC, Ryan KM, Sadoshima J, Sakagami H, Sakai Y, Sandri M, Sasakawa C, Sass M, Schneider C, Seglen PO, Seleverstov O, Settleman J, Shacka JJ, Shapiro IM, Sibirny A, Silva-Zacarin EC, Simon HU, Simone C, Simonsen A, Smith MA, Spanel-Borowski K, Srinivas V, Steeves M, Stenmark H, Stromhaug PE, Subauste CS, Sugimoto S, Sulzer D, Suzuki T, Swanson MS, Tabas I, Takeshita F, Talbot NJ, Tallóczy Z, Tanaka K, Tanaka K, Tanida I, Taylor GS, Taylor JP, Terman A, Tettamanti G, Thompson CB, Thumm M, Tolkovsky AM, Tooze SA, Truant R, Tumanovska LV, Uchiyama Y, Ueno T, Uzcátegui NL, van der Klei I, Vaquero EC, Vellai T, Vogel MW, Wang HG, Webster P, Wiley JW, Xi Z, Xiao G, Yahalom J, Yang JM, Yap G, Yin XM, Yoshimori T, Yu L, Yue Z, Yuzaki M, Zabirnyk O, Zheng X, Zhu X, Deter RL.

Autophagy. 2008 Feb;4(2):151-75. Epub 2007 Nov 21. Review.

7.

Pathways that regulate autophagy and their role in mediating tumor response to treatment.

Paglin S, Yahalom J.

Autophagy. 2006 Oct-Dec;2(4):291-3. Epub 2006 Oct 17.

PMID:
16921271
8.

Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells.

Paglin S, Lee NY, Nakar C, Fitzgerald M, Plotkin J, Deuel B, Hackett N, McMahill M, Sphicas E, Lampen N, Yahalom J.

Cancer Res. 2005 Dec 1;65(23):11061-70.

9.

The relationship between twenty missense ATM variants and breast cancer risk: the Multiethnic Cohort.

Bretsky P, Haiman CA, Gilad S, Yahalom J, Grossman A, Paglin S, Van Den Berg D, Kolonel LN, Skaliter R, Henderson BE.

Cancer Epidemiol Biomarkers Prev. 2003 Aug;12(8):733-8.

10.

Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers.

Offit K, Gilad S, Paglin S, Kolachana P, Roisman LC, Nafa K, Yeugelewitz V, Gonzales M, Robson M, McDermott D, Pierce HH, Kauff ND, Einat P, Jhanwar S, Satagopan JM, Oddoux C, Ellis N, Skaliter R, Yahalom J.

Clin Cancer Res. 2002 Dec;8(12):3813-9.

11.

A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles.

Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E, Domingo D, Yahalom J.

Cancer Res. 2001 Jan 15;61(2):439-44.

12.

Overexpression of basic fibroblast growth factor in MCF-7 human breast cancer cells: lack of correlation between inhibition of cell growth and MAP kinase activation.

Wieder R, Fenig E, Wang H, Wang Q, Paglin S, Menzel T, Gabrilove J, Fuks Z, Yahalom J.

J Cell Physiol. 1998 Dec;177(3):411-25.

PMID:
9808150
13.

Radiation-induced micronuclei formation in human breast cancer cells: dependence on serum and cell cycle distribution.

Paglin S, Delohery T, Erlandson R, Yahalom J.

Biochem Biophys Res Commun. 1997 Aug 28;237(3):678-84.

PMID:
9299426
14.

Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells.

Fenig E, Wieder R, Paglin S, Wang H, Persaud R, Haimovitz-Friedman A, Fuks Z, Yahalom J.

Clin Cancer Res. 1997 Jan;3(1):135-42.

15.
16.

Atrial natriuretic peptide inhibits the agonist-induced increase in extent of myosin light chain phosphorylation in aortic smooth muscle.

Paglin S, Takuwa Y, Kamm KE, Stull JT, Gavras H, Rasmussen H.

J Biol Chem. 1988 Sep 15;263(26):13117-20.

17.

Interaction of angiotensin II with functional smooth muscle cells in culture.

Paglin S, Stukenbrok H, Joyce NC, Jamieson JD.

Am J Physiol. 1987 Dec;253(6 Pt 1):C872-82.

PMID:
3425708
18.

Interaction of angiotensin II with dispersed cells from the anterior pituitary of the male rat.

Paglin S, Stukenbrok H, Jamieson JD.

Endocrinology. 1984 Jun;114(6):2284-92.

PMID:
6327241
19.

Covalent crosslinking of angiotensin II to its binding sites in rat adrenal membranes.

Paglin S, Jamieson JD.

Proc Natl Acad Sci U S A. 1982 Jun;79(12):3739-43.

21.

Morphologic evidence suggestive of host-tumor cell interactions in vivo in human cancer patients.

Sulitzeanu D, Gorsky Y, Paglin S, Weiss D.

J Natl Cancer Inst. 1974 Feb;52(2):603. No abstract available.

PMID:
4816013

Supplemental Content

Loading ...
Support Center